6-160731262-A-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The NM_000301.5(PLG):c.1438+30A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.253 in 1,567,980 control chromosomes in the GnomAD database, including 55,153 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.21 ( 4000 hom., cov: 32)
Exomes 𝑓: 0.26 ( 51153 hom. )
Consequence
PLG
NM_000301.5 intron
NM_000301.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.822
Publications
14 publications found
Genes affected
PLG (HGNC:9071): (plasminogen) The plasminogen protein encoded by this gene is a serine protease that circulates in blood plasma as an inactive zymogen and is converted to the active protease, plasmin, by several plasminogen activators such as tissue plasminogen activator (tPA), urokinase plasminogen activator (uPA), kallikrein, and factor XII (Hageman factor). The conversion of plasminogen to plasmin involves the cleavage of the peptide bond between Arg-561 and Val-562. Plasmin cleavage also releases the angiostatin protein which inhibits angiogenesis. Plasmin degrades many blood plasma proteins, including fibrin-containing blood clots. As a serine protease, plasmin cleaves many products in addition to fibrin such as fibronectin, thrombospondin, laminin, and von Willebrand factor. Plasmin is inactivated by proteins such as alpha-2-macroglobulin and alpha-2-antiplasmin in addition to inhibitors of the various plasminogen activators. Plasminogen also interacts with plasminogen receptors which results in the retention of plasmin on cell surfaces and in plasmin-induced cell signaling. The localization of plasminogen on cell surfaces plays a role in the degradation of extracellular matrices, cell migration, inflamation, wound healing, oncogenesis, metastasis, myogenesis, muscle regeneration, neurite outgrowth, and fibrinolysis. This protein may also play a role in acute respiratory distress syndrome (ARDS) which, in part, is caused by enhanced clot formation and the suppression of fibrinolysis. Compared to other mammals, the cluster of plasminogen-like genes to which this gene belongs has been rearranged in catarrhine primates. [provided by RefSeq, May 2020]
PLG Gene-Disease associations (from GenCC):
- hypoplasminogenemiaInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- angioedema, hereditary, 4Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant 6-160731262-A-G is Benign according to our data. Variant chr6-160731262-A-G is described in ClinVar as Benign. ClinVar VariationId is 1245480.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.287 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.211 AC: 32130AN: 152076Hom.: 4004 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
32130
AN:
152076
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.209 AC: 52344AN: 250586 AF XY: 0.213 show subpopulations
GnomAD2 exomes
AF:
AC:
52344
AN:
250586
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.258 AC: 364745AN: 1415786Hom.: 51153 Cov.: 24 AF XY: 0.255 AC XY: 180216AN XY: 707122 show subpopulations
GnomAD4 exome
AF:
AC:
364745
AN:
1415786
Hom.:
Cov.:
24
AF XY:
AC XY:
180216
AN XY:
707122
show subpopulations
African (AFR)
AF:
AC:
3127
AN:
32526
American (AMR)
AF:
AC:
5713
AN:
44644
Ashkenazi Jewish (ASJ)
AF:
AC:
7510
AN:
25864
East Asian (EAS)
AF:
AC:
21
AN:
39522
South Asian (SAS)
AF:
AC:
9149
AN:
85460
European-Finnish (FIN)
AF:
AC:
13975
AN:
53302
Middle Eastern (MID)
AF:
AC:
1421
AN:
5600
European-Non Finnish (NFE)
AF:
AC:
309636
AN:
1070012
Other (OTH)
AF:
AC:
14193
AN:
58856
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
11300
22601
33901
45202
56502
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
9678
19356
29034
38712
48390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.211 AC: 32122AN: 152194Hom.: 4000 Cov.: 32 AF XY: 0.207 AC XY: 15390AN XY: 74408 show subpopulations
GnomAD4 genome
AF:
AC:
32122
AN:
152194
Hom.:
Cov.:
32
AF XY:
AC XY:
15390
AN XY:
74408
show subpopulations
African (AFR)
AF:
AC:
4319
AN:
41534
American (AMR)
AF:
AC:
2990
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
AC:
1059
AN:
3468
East Asian (EAS)
AF:
AC:
9
AN:
5178
South Asian (SAS)
AF:
AC:
492
AN:
4824
European-Finnish (FIN)
AF:
AC:
2776
AN:
10604
Middle Eastern (MID)
AF:
AC:
64
AN:
294
European-Non Finnish (NFE)
AF:
AC:
19735
AN:
67982
Other (OTH)
AF:
AC:
475
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1303
2606
3909
5212
6515
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
338
676
1014
1352
1690
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
164
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Jun 19, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.